🏅 FDA Orphan Designation

Digibind

Digoxin immune FAB (Ovine)

Manufacturer: Glaxo Wellcome Inc.

Indicated for:

Rare disorder potentially indicated for transplant or complication after transplantationOrphan

FDA-Approved Indications (1)

Rare disorder potentially indicated for transplant or complication after transplantationOrphan Designation

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.